Preventing COVID-19 Complications With Low- and High-dose Anticoagulation
NCT04345848
·
clinicaltrials.gov ↗
PHASE3
Phase
TERMINATED
Status
160
Enrollment
OTHER
Sponsor class
Stopped
Low recruitement
Conditions
COVID
Sars-CoV2
Interventions
DRUG:
Enoxaparin
Sponsor
University Hospital, Geneva